Biotech · Private company
Capricor Inc.
Track this companyFree. Adds Capricor Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials102 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Deramiocel (CAP-1002)Phase 3 · Muscular DystrophiesClinicalTrials.gov · fetched Nov 12, 2026
- Allogeneic Cardiosphere-Derived Cells (CAP-1002)Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- CAP-1002Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- CAP-1002Phase 2 · Muscular DystrophiesClinicalTrials.gov · fetched Nov 12, 2026
- CAP-1002 Allogeneic Cardiosphere-Derived CellsPhase 2 · Myocardial InfarctionClinicalTrials.gov · fetched Nov 12, 2026
- CenderitidePhase 2 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- Deramiocel (CAP-1002)Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- CAP-1002 Allogeneic Cardiosphere-Derived CellsCOVID-19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 22, 2022ClinicalTrials.gov NCT05126758 · fetched Nov 12, 2026
- Intravenous Infusion of CAP-1002 in Patients With COVID-19PHASE2 · COMPLETED · started Nov 15, 2020ClinicalTrials.gov NCT04623671 · fetched Nov 12, 2026
- Open-label Extension of the HOPE-2 TrialPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 5, 2020ClinicalTrials.gov NCT04428476 · fetched Nov 12, 2026
- Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)PHASE2 · COMPLETED · started Jun 21, 2018ClinicalTrials.gov NCT06304064 · fetched Nov 12, 2026
- A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyPHASE2 · COMPLETED · started Apr 4, 2018ClinicalTrials.gov NCT03406780 · fetched Nov 12, 2026
- HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)PHASE2 · COMPLETED · started Jan 7, 2016ClinicalTrials.gov NCT02485938 · fetched Nov 12, 2026
- Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal ImpairmentPHASE1_PHASE2 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02603614 · fetched Nov 12, 2026
- Safety Study of Cenderitide in Stable Chronic Heart FailurePHASE2 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02359227 · fetched Nov 12, 2026
- Allogeneic Heart Stem Cells to Achieve Myocardial RegenerationPHASE1_PHASE2 · TERMINATED · started Nov 13, 2012ClinicalTrials.gov NCT01458405 · fetched Nov 12, 2026
- CAP-1002 in Severe COVID-19 DiseaseNO_LONGER_AVAILABLEClinicalTrials.gov NCT04338347 · fetched Nov 12, 2026